Removing B2m with Nanobodies
Among those on dialysis, a build up in the blood of Beta-2 microglobulin (B2m) is responsible for potentially crippling dialysis-related amyloidosis (DRA). Nanobodies are functional antibody fragments—and, used in a resin, they captured 17 times more B2m than in earlier studies, without affecting other blood proteins. Even better, the resin can be regenerated and used again. One day, this approach may be combined with dialysis to improve treatments.
Read the full article » | Posted 03-16-2020
Related Articles
- New Measure of Home Dialysis Dropout Posted 01-16-2024
- Check out the NextKidney Neokidney HD Machine Posted 11-15-2023
- New Redsense Clamp Add-on Will Stop the Blood Pump! Posted 10-13-2023
- AWAK Technologies Raised Another $20 million for Shoulder Bag Sized Wearable PD Posted 10-13-2023